{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:30:07Z","timestamp":1787808607533,"version":"build-2784847793"},"reference-count":8,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T00:00:00Z","timestamp":1427760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contact Dermatitis"],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The monitoring of cosmetic adverse reactions (<jats:styled-content style=\"fixed-case\">CAR<\/jats:styled-content>s) in China has progressed to a new stage of development because of government institutional reforms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To discuss and formulate an appropriate model for <jats:styled-content style=\"fixed-case\">CAR<\/jats:styled-content> monitoring in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The formulation of a new <jats:styled-content style=\"fixed-case\">CAR<\/jats:styled-content>\u2010monitoring model under the administration of the Food and Drug Supervision Department is discussed on the basis of China's current national conditions and with reference to the previous <jats:styled-content style=\"fixed-case\">CAR<\/jats:styled-content>\u2010monitoring and drug\u2010monitoring models of the organization formerly known as the Ministry of Health of the People's Republic of China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The preliminary design of the <jats:styled-content style=\"fixed-case\">CAR<\/jats:styled-content>\u2010monitoring model is considered to be a long\u2010term development goal of <jats:styled-content style=\"fixed-case\">CAR<\/jats:styled-content> monitoring. The monitoring model at this stage was developed on the basis of China's national conditions; specifically, the development of a two\u2010level (national and provincial agencies) monitoring system that relies on <jats:styled-content style=\"fixed-case\">CAR<\/jats:styled-content>\u2010monitoring sentinels, and reports that cover <jats:styled-content style=\"fixed-case\">CAR<\/jats:styled-content>s with definite causal associations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This model is developed on both theoretical and practical foundations, and can function as a proper monitoring model at the initial stage of current <jats:styled-content style=\"fixed-case\">CAR<\/jats:styled-content> monitoring through an appropriate pilot programme, exploration, and improvement.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cod.12358","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T03:19:38Z","timestamp":1427858378000},"page":"29-35","source":"Crossref","is-referenced-by-count":4,"title":["Designing a new model for cosmetic adverse reaction monitoring in China"],"prefix":"10.1111","volume":"73","author":[{"given":"Changfei","family":"Lu","sequence":"first","affiliation":[{"name":"Shandong Provincial Centre for Adverse Drug Reaction Monitoring  Ji'nan Shandong 250013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Cheng","sequence":"additional","affiliation":[{"name":"National Centre for Adverse Drug Reaction Monitoring  Beijing 100045 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shen","sequence":"additional","affiliation":[{"name":"National Centre for Adverse Drug Reaction Monitoring  Beijing 100045 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejie","family":"Tian","sequence":"additional","affiliation":[{"name":"Shandong Provincial Centre for Adverse Drug Reaction Monitoring  Ji'nan Shandong 250013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Shandong Provincial Centre for Adverse Drug Reaction Monitoring  Ji'nan Shandong 250013, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Li","sequence":"additional","affiliation":[{"name":"National Centre for Adverse Drug Reaction Monitoring  Beijing 100045 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Du","sequence":"additional","affiliation":[{"name":"National Centre for Adverse Drug Reaction Monitoring  Beijing 100045 China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,31]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"Ministry of Health of the People's Republic of China.Regulations concerning the hygiene supervision over cosmetics 1989. Available at:http:\/\/www.gov.cn\/banshi\/2005-08\/01\/content19081.htm(last accessed 1 August 2005)."},{"key":"e_1_2_6_3_1","unstructured":"Ministry of Health of the People's Republic of China.Circular on the surveillance status of CARs in 2006 2007. Available at:http:\/\/www.moh.gov.cn\/mohbgt\/pw10705\/200804\/16774.shtml(last accessed 16 March 2007)."},{"key":"e_1_2_6_4_1","unstructured":"Ministry of Health of the People's Republic of China.Circular on the surveillance status of CARs in 2007 2008. Available at:http:\/\/www.moh.gov.cn\/mohbgt\/pw10807\/200808\/37502.shtml(last accessed 27 May 2008)."},{"key":"e_1_2_6_5_1","unstructured":"China Food and Drug Administration.Annual report on National Adverse Drug Reaction Monitoring (2013) 2014[cited 2014]. Available at:http:\/\/www.sda.gov.cn\/WS01\/CL0078\/99794.html. (last accessed 14 May 2014)."},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831050-00010"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12005"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2007.01.022"},{"key":"e_1_2_6_9_1","first-page":"146","article-title":"Discussion on developmental stages of Technical Work of Adverse Drug Reaction Monitoring in China","volume":"9","author":"Lu S","year":"2012","journal-title":"Chin J Pharmacovigil"}],"container-title":["Contact Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcod.12358","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cod.12358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:34:53Z","timestamp":1696293293000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cod.12358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,31]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1111\/cod.12358"],"URL":"https:\/\/doi.org\/10.1111\/cod.12358","archive":["Portico"],"relation":{},"ISSN":["0105-1873","1600-0536"],"issn-type":[{"value":"0105-1873","type":"print"},{"value":"1600-0536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,31]]}}}